|
Separately, three candidates are vying for the position of chief
financial officer (CFO) at Israel's biggest company. Israeli
members of the board of directors are demanding that an Israeli
be appointed CFO if the CEO is a foreigner, Calcalist said.
Teva <TEVA.N> was left without a permanent CEO in February after
Erez Vigodman stepped down, leaving new management to try to
restore confidence in the world's biggest generic drugmaker
after a series of missteps. CFO Eyal Desheh also said he was
resigning at the end of June.
When asked for a comment Teva referred to chairman Dr. Sol
Barer's remarks on last week's earnings call: 'We are looking
for a world-class individual with deep and broad pharmaceutical
experience, an individual with experience dealing with global
and complex companies, with a strong sense of corporate
responsibility and proven strategic and operational
capabilities," it said in an emailed statement.
Teva's Tel Aviv-listed shares were down 1.5 percent in early
afternoon trading.
During the call Barer said a number of "excellent candidates"
had been interviewed for the CEO post.
"The board will take the time it needs to find the best
candidate but I am pleased with progress we have made," he said.
When asked whether Teva might waive its requirement for the CEO
to be based in Israel, Barer said: "We are looking around the
world for the best candidate. We are committed once we find that
candidate to do what it takes to bring that candidate to Teva."
(Reporting by Tova Cohen; Editing by Greg Mahlich and Elaine
Hardcastle)
[© 2017 Thomson Reuters. All rights
reserved.] Copyright 2017 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
 |
|
